Which are the causes of Goldenhar Syndrome?

Goldenhar syndrome, also known as oculo-auriculo-vertebral spectrum (OAVS), is a complex condition primarily caused by developmental disruptions during early pregnancy, though its exact origins remain largely unknown. While most cases occur sporadically without a clear genetic cause, researchers believe it results from a combination of multifactorial influences, including potential genetic predispositions and environmental exposures during the first trimester.

What causes Goldenhar syndrome?

The exact etiology of Goldenhar syndrome is not fully understood, and the medical community classifies it as a multifactorial disorder. Think of human development like building a complex structure; in Goldenhar syndrome, a "misstep" occurs during the formation of the first and second branchial arches—the structures in the embryo that eventually become the ears, jaw, and facial bones. Because this process happens very early in gestation, between the 30th and 45th day after conception, the disruption leads to the asymmetric facial and vertebral features characteristic of the condition.

Is Goldenhar syndrome hereditary or genetic?

For the vast majority of families, Goldenhar syndrome is not inherited. Most documented cases are sporadic, meaning they occur in individuals with no family history of the condition. While rare familial cases have been reported—suggesting autosomal dominant, autosomal recessive, or X-linked inheritance patterns—these represent a very small fraction of total cases. Geneticists are currently investigating whether specific gene mutations, such as those involving the MYT1 gene or chromosomal microdeletions, might play a role in certain subtypes of the condition, but no single "Goldenhar gene" has been identified.

What are the suspected risk factors for Goldenhar syndrome?

Because the cause is often elusive, researchers distinguish between direct causes and potential risk factors. While there is no definitive "trigger," several environmental and maternal factors have been studied for their potential association with the developmental errors seen in Goldenhar syndrome:

• Maternal diabetes: Some studies suggest an increased risk in pregnancies where the mother has pre-existing diabetes.


• Medication exposure: Certain medications taken during early pregnancy (such as retinoic acid or vasoconstrictors) are being researched for their potential to disrupt vascular flow to the developing facial structures.


• Vascular disruption: A leading theory suggests that a temporary interruption in blood supply to the developing face and skull area during the first trimester may be the primary mechanism.


• Assisted Reproductive Technology (ART): Emerging research is exploring whether there is a slightly higher statistical occurrence of OAVS spectrum disorders in pregnancies conceived via IVF, though the absolute risk remains very low.

What is current research revealing about the etiology?

Current research into Goldenhar syndrome is moving away from the search for a single gene and toward understanding "developmental pathways." Scientists are using genomic sequencing to identify rare variants that might make an embryo more susceptible to environmental stressors. As part of the DiseaseMaps.org community, where 173 members have shared their experiences, researchers are better able to identify patterns that help distinguish between different clinical presentations of Goldenhar syndrome, eventually aiming to provide clearer genetic counseling for affected families.

Next steps

• Consult a Clinical Geneticist: If you are planning a family or have a child with the condition, a geneticist can perform a detailed review to rule out rare inherited forms.


• Join the Community: Connect with the 173 members on DiseaseMaps.org to share experiences and stay updated on the latest research developments.


• Maintain Specialized Care: Ensure your care team includes craniofacial specialists, pediatric otolaryngologists, and orthopedists familiar with the specific developmental needs of those with Goldenhar syndrome.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Oculo-auriculo-vertebral spectrum.


• Orphanet: Oculo-auriculo-vertebral spectrum (ORPHA:637).


• OMIM (Online Mendelian Inheritance in Man): Oculo-auriculo-vertebral spectrum (Entry #164210).


• National Center for Biotechnology Information (NCBI): Literature review on the pathogenesis of branchial arch defects.